Information:
Fel:
ID
25614
Beskrivning
Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00575471
Länk
https://clinicaltrials.gov/show/NCT00575471
Nyckelord
Versioner (1)
- 2017-09-07 2017-09-07 -
Uppladdad den
7 september 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Type 2 Diabetes NCT00575471
Eligibility Type 2 Diabetes NCT00575471
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes NCT00575471
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
hba1c >6.5% and <10%
boolean
C0019018 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
fpg >126 mg/dl (7mmol/l) and <270 mg/dl (15 mmol/l)
boolean
C0583513 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
history of type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Ketoacidosis
Item
history of ketoacidosis
boolean
C0220982 (UMLS CUI [1])
Insulin regime
Item
current insulin therapy
boolean
C0557978 (UMLS CUI [1])
C-peptide measurement
Item
c-peptide <0.5ng/ml
boolean
C0202100 (UMLS CUI [1])
Liver Dysfunction
Item
impaired hepatic function
boolean
C0086565 (UMLS CUI [1])
Congestive heart failure New York Heart Association Classification
Item
chf or history of chf (nyha stage i - iv)
boolean
C0018802 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,2])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])